The mice injected with NPTyr-CXCL9 or NPTyr-αPD-L1 that expressed comparable levels of either CXCL9 or αPD-L1 in melanoma (Fig. 4a, b) were used as controls to evaluate the independent efficacy of CXCL9 or αPD-L1. The gene discussed is CXCL9; the disease is melanoma.